Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 17, 2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 02, 2026
Circulating tumor DNA in gastrointestinal cancers: promise, pitfalls, and the path forward.
Journal: EClinicalMedicine
Published: May 13, 2026
CLO26-074: A Phase I Study of Safety and Immunogenicity of Survivin Long Peptide Vaccine (SurVaxM) in Patients with Metastatic Neuroendocrine Tumors (NETs).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
Understanding the Promise and Challenges of Tumor-Agnostic Therapy: Could One Size Really Fit All?
Journal: Cancers
Published: April 11, 2026
CLO26-074: A Phase I Study of Safety and Immunogenicity of Survivin Long Peptide Vaccine (SurVaxM) in Patients with Metastatic Neuroendocrine Tumors (NETs).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
ISDE guidelines on the management of cT2N0 esophageal cancer.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: January 23, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 07, 2026
Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis.
Journal: JNCI cancer spectrum
Published: December 23, 2025
Split immunomodulatory impact of leptin on human myeloid cells: key role of IDO1 in counteracting the immunostimulatory effect of leptin.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 05, 2025
The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis.
Journal: Targeted oncology
Published: August 13, 2025
Last Updated: 09/26/2026